These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 14011937

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [THERAPY OF THROMBOEMBOLISM AND FIBRINOLYSIS].
    SANTOSTORIBIO F.
    Prog Ter Clin; 1963 Oct; 17():9-18. PubMed ID: 14097889
    [No Abstract] [Full Text] [Related]

  • 3. [DRUGS ACTIVATING FIBRINOLYSIS. THERAPEUTIC USES].
    CAMPANI M.
    Minerva Chir; 1963 Dec 15; 18():1118-27. PubMed ID: 14118238
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Jugular thrombophlebitis in horses: a review of fibrinolysis, thrombus formation, and clinical management.
    Dias DP, de Lacerda Neto JC.
    Can Vet J; 2013 Jan 15; 54(1):65-71. PubMed ID: 23814304
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [ETIOPATHOGENESIS OF THROMBOEMBOLIC DISEASE].
    ALVAREZALONSO A.
    Angiologia; 1963 Jan 15; 15():339-45. PubMed ID: 14095125
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].
    DOUGLAS AS, MCNICOL GP.
    Recenti Prog Med; 1964 Sep 15; 37():189-217. PubMed ID: 14229145
    [No Abstract] [Full Text] [Related]

  • 12. Dysfunctional coagulation and fibrinolysis systems due to adenomyosis is a possible cause of thrombosis and menorrhagia.
    Yamanaka A, Kimura F, Yoshida T, Kita N, Takahashi K, Kushima R, Murakmai T.
    Eur J Obstet Gynecol Reprod Biol; 2016 Sep 15; 204():99-103. PubMed ID: 27543913
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fibrinolysis. VIII. Comparative study in vitro of the effects of various proteolytic agents on the blood clotting mechanism of human plasma.
    KARACA M, STEFANINI M, MELE RH, MOSSA A, SOARDI F.
    J Lab Clin Med; 1962 Jul 15; 60():117-24. PubMed ID: 14453835
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fibrinolysis. VII. Clot lysis, coagulation, and fibrinolytic mechanisms after administration of aspergillin O (mold fibrinolysin) in man.
    KARACA M, STEFANINI M, MELE R.
    J Lab Clin Med; 1962 May 15; 59():799-814. PubMed ID: 14453834
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Acute changes of coagulation and fibrinolysis parameters after experimental thromboembolic stroke and thrombolytic therapy.
    Stehling F, Weber R, Ozcelik A, Bröcker M, Volbracht L, Diener HC, Busch E.
    Neurosci Lett; 2008 Aug 15; 441(1):39-43. PubMed ID: 18597942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.